Molecular genetics of sudden cardiac death

Forensic Science International

Volumn 182, Issue 1-3, 2008, Pages 1-12

  Rodríguez Calvo, María Sol ^a   Brion, María ^b   Allegue, Catarina ^a   Concheiro, Luis ^a   Carracedo, Angel ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Channelopathies; Molecular genetics; Myocardial disease; Sudden cardiac death

Indexed keywords

BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; FORENSIC GENETICS; FORENSIC PATHOLOGY; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE; HEART RIGHT VENTRICLE DYSPLASIA; HISTOPATHOLOGY; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MOLECULAR GENETICS; MORPHOLOGY; MYOCARDIAL DISEASE; PATHOLOGIST; PREVALENCE; PRIORITY JOURNAL; REVIEW; SHORT QT SYNDROME; SUDDEN DEATH;

EID: 56449086640     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2008.09.013     Document Type: Review

References (170)

1. Virmani R., Burke A.P., and Farb A. Sudden cardiac death. Cardiovasc. Pathol. 10 (2001) 275-282
2. Bayés de Luna A., Bayés-Genís A., and Guindo J. Soldevila Muerte súbita cardíaca. Timely Topics in Medicine (1997)
3. Chugh S.S., Kelly K.L., and Titus J.L. Sudden cardiac death with apparently normal hearts. Circulation 102 (2000) 649-654
4. Liberthson R.R. Sudden death from cardiac causes in children and young adults. N. Engl. J. Med. 334 (1996) 1039-1044
5. Cohle S.D., and Sampson B.A. The negative autopsy: sudden cardiac death or other?. Cardiovasc. Pathol. 10 (2001) 219-222
6. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., and Mueller F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA 276 (1996) 199-204
7. Corrado D., Basso C., and Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc. Res. 50 (2001) 399-408
8. Puranik R., Chow C.K., Duflou J.A., Kilborn M.J., and McGuire M.A. Sudden death in the young. Heart Rhythm 2 (2005) 1277-1282
9. Morentin B., Suarez-Mier M.P., and Aguilera B. Sudden unexplained death among persons 1-35 years old. Forensic Sci. Int. 135 (2003) 213-217
10. Davies M.J., and Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310 (1984) 1137-1140
11. Drory Y., Turetz Y., Hiss Y., Lev B., Fisman E.Z., Pines A., and Kramer M.R. Sudden unexpected death in persons less than 40 years of age. Am. J. Cardiol. 68 (1991) 1388-1392
12. Neuspiel D.R., and Kuller L.H. Sudden and unexpected natural death in childhood and adolescence. JAMA 254 (1985) 1321-1325
13. Topaz O., and Edwards J.E. Pathologic features of sudden death in children, adolescents, and young adults. Chest 87 (1985) 476-482
14. Basso C., Calabrese F., Corrado D., and Thiene G. Postmortem diagnosis is sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc. Res. 50 (2001) 290-300
15. Ingles J., and Semsarian C. Sudden cardiac death in the young. Int. Med. J. 37 (2007) 32-37
16. Tester D.J., and Ackerman J. The role of molecular autopsy in unexplained sudden cardiac death. Curr. Opin. Cardiol. 21 (2006) 166-172
17. Lorin de la Grandmaison G. Is there progress in the autopsy diagnosis of the sudden unexplained death in adults?. Forensic Sci. Int. 156 (2006) 138-144
18. Richardson P., McKenna W., Bristow M., Maisch B., Mautner B., O'Connell J., Olsen E., Thiene G., Goodwin J., Gyarfas I., Martin I., and Nordet P. Report of the 1995 World Health Organization: "International Society and Federation of Cardiology Task Force on the definition and Classification of Cardiomyopathies". Circulation 93 (1996) 841-842
19. Maron B.J., McKenna W.J., Danielson G.K., Kappenberger L.J., Kuhn H.J., Seidman C.E., Shah P.M., Spencer Jr. W.H., Spirito P., Ten Cate F.J., and Wigle E.D. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J. Am. Coll. Cardiol. 42 (2003) 1687-1713
20. Maron B.J., Towbin J.A., Thiene G., Antzelevitch C., Corrado D., Arnett D., Moss A.J., Seidman C.E., and Young J.B. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113 (2006) 1807-1816
21. Elliott P., Andersson B., Arbustini E., Bilinska Z., Cecchi F., Charron P., Dubourg O., Kühl U., Maisch B., McKenna W.J., Monserrat L., Pankuweit S., Rapezzi C., Seferovic P., Tavazzi L., and Keren A. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on myocardial and pericardial diseases. Eur. Heart J. 29 (2008) 270-276
22. Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., and Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92 (1995) 785-789
23. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 287 (2002) 1308-1320
24. M. Brión, C. Allegue, P. Sánchez-Diz, R. Gil, A. Blanco-Verea, I. Quintela, M. Torres, A. Carracedo, New developments on the genetics of Sudden Cardiac Death (SCD), Forensic Sci. Int.: Genetics, in press.
25. McKenna W.J., and Camm A.J. Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 80 (1989) 1489-1492
26. Shah P.M., Adelman A.G., Wigle E.D., Gobel F.L., Burchell H.B., Hardarson T., Curiel R., de la Calzada C., Oakley C.M., and Goodwin J.F. The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. A multicenter study. Circ. Res. 35 Suppl. II (1974) 179-195
27. McKenna W., and Deanfield J. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch. Dis. Child. 59 (1984) 971-975
28. Kofflard M.J., Waldstein D.J., Vos J., and ten Cate F.J. Prognosis in hypertrophic cardiomyopathy observed in a large clinic population. Am. J. Cardiol. 72 (1993) 939-943
29. Cannan C.R., Reeder G.S., Bailey K.R., Melton III L.J., and Gersh B.J. Natural history of hypertrophic cardiomyopathy: a population based study, 1976 through 1990. Circulation 92 (1995) 2488-2495
30. Davies M.J., and McKenna W.J. Hypertrophic cardiomyopathy-pathology and pathogenesis. Histopathology 26 (1995) 493-500
31. Wigle E.D., and Cardiomyopathy. The diagnosis of hypertrophic cardiomyopathy. Heart 86 (2001) 709-714
32. Geisterfer-Lowrance A.A., Kass S., Tanigawa G., Vosberg H.P., McKenna W., Seidman C.E., and Seidman J.G. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62 (1990) 999-1006
33. Poetter K., Jiang H., Hassanzadeh S., Master S.R., Chang A., Dalakas M.C., Rayment I., Sellers J.R., Fananapazir L., and Epstein N.D. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13 (1996) 63-69
34. Watkins H., Conner D., Thierfelder L., Jarcho J.A., MacRae C., McKenna W.J., Maron B.J., Seidman J.G., and Seidman C.E. Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nat. Genet. 11 (1995) 434-437
35. Thierfelder L., Watkins H., MacRae C., Lamas R., McKenna W., Vosberg H.P., Seidman J.G., and Seidman C.E. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77 (1994) 701-712
36. Kimura A., Harada H., Park J.E., Nishi H., Satoh M., Takahashi M., Hiroi S., Sasaoka T., Ohbuchi N., Nakamura T., Koyanagi T., Hwang T.H., Choo J.A., Chung K.S., Hasegawa A., Nagai R., Okazaki O., Nakamura H., Matsuzaki M., Sakamoto T., Toshima H., Koga Y., Imaizumi T., and Sasazuki T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nat. Genet. 16 (1997) 379-382
37. Olson T.M., Karst M.L., Whitby F.G., and Driscoll D.J. Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology. Circulation 105 (2002) 2337-2340
38. Mogensen J., Klausen I.C., Pedersen A.K., Egeblad H., Bross P., Kruse T.A., Gregersen N., Hansen P.S., Baandrup U., and Borglum A.D. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. J. Clin. Invest. 103 (1999) R39-R43
39. Satoh M., Takahashi M., Sakamoto T., Hiroe M., Marumo F., and Kimura A. Structural analysis of the titin gene in hypertrophic cardiomyopathy: identification of a novel disease gene. Biochem. Biophys. Res. Commun. 262 (1999) 411-417
40. Niimura H., Bachinski L.L., Sangwatanaroj S., Watkins H., Chudley A.E., McKenna W., Kristinsson A., Roberts R., Sole M., Maron B.J., Seidman J.G., and Seidman C.E. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N. Engl. J. Med. 338 (1998) 1248-1257
41. Hoffmann B., Schmidt-Traub H., Perrot A., Osterziel K.J., and Gessner R. First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy. Hum. Mutat. 17 6 (2001) 524
42. Richard P., Charron P., Carrier L., Ledeuil C., Cheav T., Pichereau C., Benaiche A., Isnard R., Dubourg O., Burban M., Gueffet J.P., Millaire A., Desnos M., Schwartz K., Hainque B., and Komajda M. EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107 (2003) 2227-2232
43. Van Driest S.L., Vasile V.C., Ommen S.R., Will M.L., Tajik A.J., Gersh B.J., and Ackerman M.J. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 1903-1910
44. Van Driest S.L., Jaeger M.A., Ommen S.R., Will M.L., Gersh B.J., Tajik A.J., and Ackerman M.J. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 602-610
45. Morner S., Richard P., Kazzam E., Hellman U., Hainque B., Schwartz K., and Waldenström A. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J. Mol. Cell Cardiol. 35 (2003) 841-849
46. Erdmann J., Daehmlow S., Wischke S., Senyuva M., Werner U., Raible J., Tanis N., Dyachenko S., Hummel M., Hetzer R., and Regitz-Zagrosek V. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin. Genet. 64 (2003) 339-349
47. Watkins H., Thierfelder L., Hwang D.S., McKenna W., Seidman J.G., and Seidman C.E. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J. Clin. Invest. 90 (1992) 1666-1671
48. Watkins H., Anan R., Coviello D.A., Spirito P., Seidman J.G., and Seidman C.E. A de novo mutation in alpha-tropomyosin that causes hypertrophic cardiomyopathy. Circulation 91 (1995) 2302-2305
49. Richard P., Isnard R., Carrier L., Dubourg O., Donatien Y., Mathieu B., Bonne G., Gary F., Charron P., Hagege M., Komajda M., Schwartz K., and Hainque B. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J. Med. Genet. 36 (1999) 542-545
50. Ingles J., Doolan A., Chiu C., Seidman J., Seidman C., and Semsarian C. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J. Med. Genet. 42 (2005) e59
51. Watkins H., Rosenzweig A., Hwang D.S., Levi T., McKenna W., Seidman C.E., and Seidman J.G. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N. Engl. J. Med. 326 (1992) 1108-1114
52. Anan R., Greve G., Thierfelder L., Watkins H., McKenna W.J., Solomon S., Vecchio C., Shono H., Nakao S., Tanaka H., Mares Jr. A., Towbin J.A., Spirito P., Roberts R., Seidman J.G., and Seidman C.E. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy. J. Clin. Invest. 93 (1994) 280-285
53. Coviello D.A., Maron B.J., Spirito P., Watkins H., Vosberg H.P., Thierfelder L., Schoen F.J., Seidman J.G., and Seidman C.E. Clinical features of hypertrophic cardiomyopathy caused by mutation of a 'hot spot' in the alpha-tropomyosin gene. J. Am. Coll. Cardiol. 29 (1997) 635-640
54. Moolman J.C., Corfield V.A., Posen B., Ngumbela K., Seidman C., Brink P.A., and Watkins H. Sudden death due to troponin T mutations. J. Am. Coll. Cardiol. 29 (1997) 549-555
55. Varnava A., Baboonian C., Davison F., de Cruz L., Elliott P.M., Davies M.J., and McKenna W.J. A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy. Heart 82 (1999) 621-624
56. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., and McKenna W.J. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J. Am. Coll. Cardiol. 36 (2000) 2212-2218
57. Seidman J.G., and Seidman C. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 104 (2001) 557-567
58. Niimura H., Patton K.K., McKenna W.J., Soults J., Maron B.J., Seidman J.G., and Seidman C.E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105 (2002) 446-451
59. Ackerman M.J., Van Driest S.L., Ommen S.R., Will M.L., Nishimura R.A., Tajik A.J., and Gersh B.J. Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T gene in hypertrophic cardiomyopathy: a comprehensive outpatient perspective. J. Am. Coll. Cardiol. 39 (2002) 2042-2048
60. Van Driest S.L., Maron B.J., and Ackerman M.J. From malignant mutations to malignant domains: the continuing search for prognostic significance in the mutant genes causing hypertrophic cardiomyopathy [Comment]. Heart 90 (2004) 7-8
61. Van Driest S.V., Ackerman M.J., Ommen S.R., Shakur R., Will M.L., Nishimura R.A., Tajik A.J., and Gersh B.J. Prevalence and severity of 'benign' mutations in the beta myosin heavy chain, cardiac troponin-T, and alpha tropomyosin genes in hypertrophic cardiomyopathy. Circulation 106 (2002) 3085-3090
62. Van Driest S.L., Vasile V.C., Ommen S.R., Will M.L., Tajik A.J., Gersh B.J., and Ackerman M.J. Myosin binding protein C mutations and compound herterozygosity in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 1903-1910
63. Richard P., Villard E., Charron P., and Isnard R. The genetic bases of cardiomyopathies. J. Am. Coll. Cardiol. 48 (2006) A79-89
64. Bos J.M., Ommen S.R., and Ackerman M.J. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?. Curr. Opin. Cardiol. 22 (2007) 193-199
65. Geier C., Perrot A., Ozcelik C., Binner P., Counsell D., Hoffmann K., Pilz B., Martiniak Y., Gehmlich K., van der Ven P.F., Fürst D.O., Vornwald A., von Hodenberg E., Nürnberg P., Scheffold T., Dietz R., and Osterziel K.J. Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation 107 (2003) 1390-1395
66. Hayashi T., Arimura T., Itoh-Satoh M., Ueda K., Hohda S., Inagaki N., Takahashi M., Hori H., Yasunami M., Nishi H., Koga Y., Nakamura H., Matsuzaki M., Choi B.Y., Bae S.W., You C.W., Han K.H., Park J.E., Knöll R., Hoshijima M., Chien K.R., and Kimura A. T cap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J. Am. Coll. Cardiol. 44 (2004) 2192-2201
67. Theis J.L., Bos J.M., Bartleson V.B., Will M.L., Binder J., Vatta M., Towbin J.A., Gersh B.J., Ommen S.R., and Ackerman M.J. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 351 (2006) 896-902
68. Vasile V.C., Will M.L., Ommen S.R., Edwards W.D., Olson T.M., and Ackerman M.J. Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy. Mol. Genet. Metab. 87 (2006) 169-174
69. Vasile V.C., Ommen S.R., Edwards W.D., and Ackerman M.J. A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 345 (2006) 998-1003
70. Minamisawa S., Sato Y., Tatsuguchi Y., Fujino T., Imamura S., Uetsuka Y., Nakazawa M., and Matsuoka R. Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy. Biochem. Biophys. Res. Commun. 304 (2003) 1-4
71. Haghighi K., Kolokathis F., Gramolini A.O., Waggoner J.R., Pater L., Lynch R.A., Fan G.C., Tsiapras D., Parekh R.R., Dorn II G.W., MacLennan D.H., Kremastinos D.T., and Kranias E.G. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1388-1393
72. Fujino N., Ino H., Hayashi K., Uchiyama K., Nagata M., Konno T., Katoh H., Sakamoto Y., Tsubokawa T., Ohsato K., Mizuno S., and Yamagishi M. A novel missense mutation in cardiac ryanodine receptor gene as a possible cause of hypertrophic cardiomyopathy: evidence from familial analysis [Abstract]. Circulation 114 (2006) II_165
73. Landstrom A.P., Weisleder N., Batalden K.B., Bos J.M., Tester D.J., Ommen S.R., Wehrens X.H., Claycomb W.C., Ko J.K., Hwang M., Pan Z., Ma J., and Ackerman M.J. Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans. J. Mol Cell. Cardiol. 42 (2007) 1026-1035
74. Arad M., Maron B.J., Gorham J.M., Johnson Jr. W.H., Saul J.P., Perez-Atayde A.R., Spirito P., Wright G.B., Kanter R.J., Seidman C.E., and Seidman J.G. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N. Engl. J. Med. 352 (2005) 362-372
75. Van Driest S.L., Gakh O., Ommen S.R., Isaya G., and Ackerman M.J. Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy. Mol. Genet. Metab. 85 (2005) 280-285
76. Nakao S., Takenaka T., Maeda M., Kodama C., Tanaka A., Tahara M., Yoshida A., Kuriyama M., Hayashibe H., Sakuraba H., and Tanaka H. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N. Engl. J. Med. 333 (1995) 288-293
77. Priori S.G., and Napolitano C. Role of genetic analyses in cardiology. Part I: Mendelian diseases: cardiac channelopathies. Circulation 113 (2006) 1130-1135
78. Thiene G., Nava A., Corrado D., Rossi L., and Pennelli N. Right ventricular cardiomyopathy and sudden death in young people. N. Engl. J. Med. 318 (1988) 129-133
79. Gallo P., D'Amati G., and Pellicia F. Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Hum. Pathol. 23 (1992) 948-952
80. McKoy G., Protonotarios N., Crosby A., Tsatsopoulou A., Anastasakis A., Coonar A., Norman M., Baboonian C., Jeffery S., and McKenna W.J. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 355 (2000) 2119-2124
81. Rampazzo A., Nava A., Malacrida S., Beffagna G., Bauce B., Rossi V., Zimbello R., Simionati B., Basso C., Thiene G., Towbin J.A., and Danieli G.A. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 71 (2002) 1200-1206
82. Gerull B., Heuser A., Wichter T., Paul M., Basson C.T., McDermott D.A., Lerman B.B., Markowitz S.M., Ellinor P.T., MacRae C.A., Peters S., Grossmann K.S., Drenckhahn J., Michely B., Sasse-Klaassen S., Birchmeier W., Dietz R., Breithardt G., Schulze-Bahr E., and Thierfelder L. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36 (2004) 1162-1164
83. Pilichou K., Nava A., Basso C., Beffagna G., Bauce B., Lorenzon A., Frigo G., Vettori A., Valente M., Towbin J., Thiene G., Danieli G.A., and Rampazzo A. Mutations in desmoglein-2 gene are associated to arrhythmogenic right ventricular cardiomyopathy. Circulation 113 (2006) 1171-1179
84. Syrris P., Ward D., Evans A., Asimaki A., Gandjbakhch E., Sen-Chowdhry S., and McKenna W.J. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am. J. Hum. Genet. 79 (2006) 978-984
85. Rampazzo A., Nava A., Danieli G.A., Buja G., Daliento L., Fasoli G., Scognamiglio R., Corrado D., and Thiene G. The gene for arrhythmogenic right ventricular cardiomyopathy maps to chromosome 14q23-q24. Hum Mol Genet. 3 (1994) 959-962
86. Norgett E.E., Hatsell S.J., Carvajal-Huerta L., Cabezas J.C., Common J., Purkis P.E., Whittock N., Leigh I.M., Stevens H.P., and Kelsell D.P. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum. Mol. Genet. 9 (2000) 2761-2766
87. Tiso N., Stephan D.A., Nava A., Bagattin A., Devaney J.M., Stanchi F., Larderet G., Brahmbhatt B., Brown K., Bauce B., Muriago M., Basso C., Thiene G., Danieli G.A., and Rampazzo A. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10 (2001) 189-194
88. Beffagna G., Occhi G., Nava A., Vitiello L., Ditadi A., Basso C., Bauce B., Carraro G., Thiene G., Towbin J.A., Danieli G.A., and Rampazzo A. Regulatory mutations in transforming growth factor-beta 3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc. Res. 65 (2005) 366-373
89. Sen-Chowdhry S., Syrris P., Ward D., Asimaki A., Sevdalis E., and McKenna W.J. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 115 (2007) 1710-1720
90. Corrado D., and Thiene G. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. Circulation 113 (2006) 1634-1637
91. Dalal D., Molin L.H., Piccini J., Tichnell C., James C., Bomma C., Prakasa K., Towbin J.A., Marcus F.I., Spevak P.J., Bluemke D.A., Abraham T., Russell S.D., Calkins H., and Judge D.P. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 113 (2006) 1641-1649
92. van Tintelen J.P., Entius M.M., Bhruiyan Z.A., Jongbloed R., Wiesfeld A.C.P., Wilde A.A.M., van der Smagt J., Boven L.G., Mannens M.M.A.M., van Langen I.M., Hofstra R.M.W., Otterspoor L.C., Doevendans P.A.F.M., Rodriguez L.-M., van Gelder I.C., and Hauer R.N.W. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 113 (2006) 1650-1658
93. Syrris P., Ward D., Asimaki A., Sen-Chowdhry S., Ebrahim H.Y., Evans A., Hitomi N., Norman M., Pantazis A., Shaw A.L., Elliott P.M., and McKenna W.J. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 113 (2006) 356-364
94. van Tintelen J.P., Hofstra R.M., Wiesfeld A.C., van den Berg M.P., Hauer R.N., and Jongbloed J.D. Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?. Curr. Opin. Cardiol. 22 3 (2007) 185-192
95. Sen-Chowdhry S., Syrris P., and McKenna W.J. Role of Genetic Analysis in the Management of Patients with Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy. J. Am. Coll. Cardiol. 50 (2007) 1813-1821
96. Marban E. Cardiac channelopathies. Nature 415 (2002) 213-218
97. Tester D.J., and Ackerman M.J. Sudden infant death syndrome: how significant are the cardiac channelopathies?. Cardiovasc. Res. 67 (2005) 388-396
98. Wever E.F., and Robles de Medina E.O. Sudden death in patients without structural heart disease. J. Am. Coll. Cardiol. 43 (2004) 1137-1144
99. Ackerman M.J. Cardiac channelopathies: it's in the genes. Nat. Med. 10 (2004) 463-464
100. Keating M.T., and Sanguinetti M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104 (2001) 569-580
101. Ackerman M.J., and Clapham D.E. Ion channels-basic science and clinical disease. N. Engl. J. Med. 336 (1997) 1575-1586
102. Schwartz P.J. The congenital long QT syndromes from genotype to phenotype: clinical implications. J. Intern. Med. 259 (2006) 39-47
103. Jervell A., and Lang-Nielsen F. Congenital deaf mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am. Heart J. 54 (1957) 59-65
104. Romano C., Gemme G., and Pongiglione R. Aritmie cardiache rare in eta pediatrica. Clin. Pediatr. 45 (1963) 656-683
105. Ward O.C. A new familial cardiac syndrome in children. J. Indian Med. Assoc. 54 (1964) 103-106
106. Keating M., Dunn C., Atkinson A., Timothy K., Vincent G.M., and Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 252 (1991) 704-706
107. Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M., Van Raay T.J., Shen J., Timothy K.W., Vincent G.M., de Jager T., Schwartz P.J., Towbin J.A., Moss A.J., Atkinson D.L., Landes G.M., Connors T.D., and Keating M.T. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12 (1996) 17-23
108. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., and Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80 (1995) 795-803
109. Wang Q., Shen J., Splawski I., Atkinson D., Li Z., Robinson J.L., Moss A.J., Towbin J.A., and Keating M.T. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80 (1995) 805-811
110. Splawski I., Tristani-Firouzi M., Lehmann M.H., Sanguinetti M.C., and Keating M.T. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat. Genet. 17 (1997) 338-340
111. Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H., Timothy K.W., Keating M.T., and Goldstein S.A. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 97 (1999) 175-187
112. Mohler P.J., Schott J.J., Gramolini A.O., Dilly K.W., Guatimosim S., duBell W.H., Song L.S., Haurogne K., Kyndt F., Ali M.E., Rogers T.B., Lederer W.J., Escande D., Le Marec H., and Bennett V. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421 (2003) 634-639
113. Plaster N.M., Tawil R., Tristani-Firouzi M., Canun S., Bendahhou S., Tsunoda A., Donaldson M.R., Iannaccone S.T., Brunt E., Barohn R., Clark J., Deymeer F., George Jr. A.L., Fish F.A., Hahn A., Nitu A., Ozdemir C., Serdaroglu P., Subramony S.H., Wolfe G., Fu Y.H., and Ptácek L.J. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105 (2001) 511-519
114. Splawski I., Timothy K.W., Sharpe L.M., Decher N., Kumar P., Bloise R., Napolitano C., Schwartz P.J., Joseph R.M., Condouris K., Tager-Flusberg H., Priori S.G., Sanguinetti M.C., and Keating M.T. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119 (2004) 19-31
115. Vatta M., Ackerman M., Ye B., Makielski J., Ughanze E., Taylor E.W., Tester D.J., Balijepalli R.C., Foell J.D., Li Z., Kamp T.J., and Towbin J.A. Mutant Caveolin-3 induces persistent late sodium current and is associated with long QT syndrome. Circulation 114 20 (2006) 2104-2112
116. Medeiros A., Kaku T., Tester D.J., Iturralde P., Itty A., Ye B., Valdivia J., Makielski S., Quintero S., Luna T., and Ackerman M.J. Sodium channel B4 subunit mutation causes congenital long QT syndrome. Heart Rhythm 3 (2006) S34
117. Splawski I., Shen J., Timothy K.W., Lehmann M.H., Priori S., Robinson J.L., Moss A.J., Schwartz P.J., Towbin J.A., Vincent G.M., and Keating M.T. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 102 (2000) 1178-1185
118. Tester D.J., Will M.L., Haglund C.M., and Ackerman M.J. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2 (2005) 507-517
119. Napolitano C., Ronchetti E., Memmi M., Nastoli J., Faggiano G., Schwartz P.J., and Priori S.G. Molecular epidemiology of the long QT syndrome in a cohort of 267 probands. J. Am. Coll. Cardiol. 37 Suppl. A (2001) 87A
120. Priori S.G. Inherited arrhythmogenic diseases: the complexity beyond monogenic disorders. Circ Res. 94 (2004) 140-145
121. Priori S.G., Napolitano C., and Schwartz P.J. Low penetrance in the long-QT syndrome: clinical impact. Circulation 99 (1999) 529-533
122. Neyroud N., Tesson F., Denjoy I., Leibovici M., Donger C., Barhanin J., Faure S., Gary F., Coumel P., Petit C., Schwartz K., and Guicheney P. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome. Nat. Genet. 15 (1997) 186-189
123. Schwartz P.J., Priori S.G., Spazzolini C., Moss A.J., Vincent G.M., Napolitano C., Denjoy I., Guicheney P., Breithardt G., Keating M.T., Towbin J.A., Beggs A.H., Brink P., Wilde A.A., Toivonen L., Zareba W., Robinson J.L., Timothy K.W., Corfield V., Wattanasirichaigoon D., Corbett C., Haverkamp W., Schulze-Bahr E., Lehmann M.H., Schwartz K., Coumel P., and Bloise R. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
124. Moss A.J., Zareba W., Kaufman E.S., Gartman E., Peterson D.R., Benhorin J., Towbin J.A., Keating M.T., Priori S.G., Schwartz P.J., Vincent G.M., Robinson J.L., Andrews M.L., Feng C., Hall W.J., Medina A., Zhang L., and Wang Z. Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105 (2002) 794-799
125. Priori S.G., Schwartz P.J., Napolitano C., Bloise R., Ronchetti E., Grillo M., Vicentini A., Spazzolini C., Nastoli J., Bottelli G., Folli R., and Cappelletti D. Risk stratification in the long-QT syndrome. N. Engl. J. Med. 348 (2003) 1866-1874
126. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report (see comments). J. Am. Coll. Cardiol. 20 (1992) 1391-1396
127. Hata Y., Chiba N., and Hotta K. Incidence and clinical significance of right bundle branch block and ST-segment elevation in V1-V3 in 6- to 18-year old schoolchildren in Japan. Circulation 20 (1997) 2310
128. Hermida J.S., Lemoine J.L., Aoun F.B., Jarry G., Rey J.L., and Quiret J.C. Prevalence of the Brugada syndrome in an apparently healthy population. Am. J. Cardiol. 86 (2000) 91-94
129. Vatta M., Dumaine R., Varghese G., Richard T.A., Shimizu W., Aihara N., Nademanee K., Brugada R., Brugada J., Veerakul G., Li H., Bowles N.E., Brugada P., Antzelevitch C., and Towbin J.A. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum. Mol. Genet. 11 (2002) 337-345
130. Chen Q., Kirsch G.E., Zhang D., Brugada R., Brugada J., Brugada P., Potenza D., Moya A., Borggrefe M., Breithardt G., Ortiz-Lopez R., Wang Z., Antzelevitch C., O'Brien R.E., Schulze-Bahr E., Keating M.T., Towbin J.A., and Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 392 (1998) 293-296
131. Priori S.G., Napolitano C., Gasparini M., Pappone C., Della Bella P., Brignole M., Giordano U., Giovannini T., Menozzi C., Bloise R., Crotti L., Terreni L., and Schwartz P.J. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 102 (2000) 2509-2515
132. Morita H., Kusano-Fukushima K., Nagase S., Fujimoto Y., Hisamatsu K., Fujio H., Haraoka K., Kobayashi M., Morita S.T., Nakamura K., Emori T., Matsubara H., Hina K., Kita T., Fukatani M., and Ohe T. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J. Am. Coll. Cardiol. 40 (2002) 1437-1444
133. Antzelevitch C. Genetic basis of Brugada syndrome. Heart Rhythm 4 (2007) 756-757
134. Schott J.J., Alshinawi C., Kyndt F., Probst V., Hoorntje T.M., Hulsbeek M., Wilde A.A., Escande D., Mannens M.M., and Le Marec H. Cardiac conduction defects associate with mutations in SCN5A. Nat. Genet. 23 (1999) 20-21
135. Benson D.W., Wang D.W., Dyment M., Knilans T.K., Fish F.A., Strieper M.J., Rhodes T.H., and George Jr. A.L. Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112 (2003) 1019-1028
136. Watanabe H., Koopmann T.T., Le Scouarnec S., Yang T., Ingram C.R., Schott J.J., Demolombe S., Probst V., Anselme F., Escande D., Wiesfeld A.C., Pfeufer A., Kääb S., Wichmann H.E., Hasdemir C., Aizawa Y., Wilde A.A., Roden D.M., and Bezzina C.R. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J. Clin. Invest. 118 6 (2008) 2260-2268
137. Mohler P.J., Rivolta I., Napolitano C., LeMaillet G., Lambert S., Priori S.G., and Bennett V. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1. 5 on the surface of cardiomyocytes. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17533-17538
138. London B., Michalec M., Mehdi H., Zhu X., Kerchner L., Sanyal S., Viswanathan P.C., Pfahnl A.E., Shang L.L., Madhusudanan M., Baty C.J., Lagana S., Aleong R., Gutmann R., Ackerman M.J., McNamara D.M., Weiss R., and Dudley Jr. S.C. Mutation in glycerol-3- phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na current and causes inherited arrhythmias. Circulation 116 (2007) 2260-2268
139. Antzelevitch C., Pollevick G.D., Cordeiro J.M., Casis O., Sanguinetti M.C., Aizawa Y., Guerchicoff A., Pfeiffer R., Oliva A., Wollnik B., Gelber P., Bonaros Jr. E.P., Burashnikov E., Wu Y., Sargent J.D., Schickel S., Oberheiden R., Bhatia A., Hsu L.F., Haïssaguerre M., Schimpf R., Borggrefe M., and Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 115 (2007) 442-449
140. Bezzina C.R., Shimizu W., Yang P., Koopmann T.T., Tanck M.W., Miyamoto Y., Kamakura S., Roden D.M., and Wilde A.A. Common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 113 (2006) 338-344
141. Priori S.G., Napolitano C., Gasparini M., Pappone C., Bella P.D., Giordano U., Bloise R., Giustetto C., De Nardis R., Grillo M., Ronchetti E., Faggiano G., and Nastoli J. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105 (2002) 1342-1347
142. Coumel P., Fidelle J., Lucet V., Attuel P., and Bouvrain Y. Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases. Br. Heart J. 40 Suppl. (1978) 28-37
143. Leenhardt A., Lucet V., Denjoy I., Grau F., Ngoc D.D., and Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91 (1995) 1512-1519
144. Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., Sorrentino V., and Danieli G.A. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 (2001) 196-200
145. Laitinen P.J., Brown K.M., Piippo K., Swan H., Devaney J.M., Brahmbhatt B., Donarum E.A., Marino M., Tiso N., Viitasalo M., Toivonen L., Stephan D.A., and Kontula K. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103 (2001) 485-490
146. Lahat H., Pras E., Olender T., et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am. J. Hum. Genet. 69 (2001) 1378-1384
147. Priori S.G., Napolitano C., Memmi M., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106 (2002) 69-74
148. Cerrone M., Colombi B., Bloise R., Memmi M., Moncalvo C., Potenza D., Drago F., Napolitano C., Bradley D.J., and Priori S.G. Clinical and molecular characterization of a large cohort of patients affected with catecholaminergic polymorphic ventricular tachycardia. Circulation 110 Suppl. II (2004) 552-553
149. Choi G., Kopplin L.J., Tester D.J., Will M.L., Haglund C.M., and Ackerman M.J. Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes. Circulation 110 (2004) 2119-2124
150. Tester D.J., Carturan E., Dura M., Reiken S., Wronska A., Marks A.R., and Ackerman M.J. Molecular and functional characterization of novel RyR2-encoded cardiac ryanodine receptor/calcium release channel mutations in sudden infant death syndrome. Heart Rhythm 3 Suppl. I (2006) S67
151. Di Barletta M.R., Viatchenko-Karpinski S., Nori A., Memmi M., Terentyev D., Turcato F., Valle G., Rizzi N., Napolitano C., Gyorke S., Volpe P., and Priori S.G. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia. Circulation 114 (2006) 1012-1019
152. Gussak I., Brugada P., Brugada J., Wright R.S., Kopecky S.L., Chaitman B.R., and Bjerregaard P. Idiopathic short QT interval: a new clinical syndrome?. Cardiology 94 (2000) 99-102
153. Gaita F., Giustetto C., Bianchi F., Wolpert C., Schimpf R., Riccardi R., Grossi S., Richiardi E., and Borggrefe M. Short QT syndrome. A familial cause of sudden death. Circulation 108 (2003) 965
154. Bellocq C., van Ginneken A.C.G., Bezzina C.R., Alders M., Escande D., Mannens M.M., Baró I., and Wilde A.A. Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109 (2004) 2394-2397
155. Brugada R., Hong K., Dumaine R., Cordeiro J., Gaita F., Borggrefe M., Menendez T.M., Brugada J., Pollevick G.D., Wolpert C., Burashnikov E., Matsuo K., Wu Y.S., Guerchicoff A., Bianchi F., Giustetto C., Schimpf R., Brugada P., and Antzelevitch C. Sudden death associated with short-QT syndrome linked to mutations in HERG. Circulation 109 (2004) 30-35
156. Priori S.G., Pandit S.V., Rivolta I., Berenfeld O., Ronchetti E., Dhamoon A., Napolitano C., Anumonwo J., di M.R., Barletta S., Gudapakkam G., Bosi M., Stramba-Badiale J., and Jalife. A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ. Res. 96 (2005) 800-807
157. Chen Y.H., Xu S.J., Bendahhou S., Wang X.L., Wang Y., Xu W.Y., Jin H.W., Sun H., Su X.Y., Zhuang Q.N., Yang Y.Q., Li Y.B., Liu Y., Xu H.J., Li X.F., Ma N., Mou C.P., Chen Z., Barhanin J., and Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 299 (2003) 251-254
158. Vanezis P., and Leadbeatter S. Next of kin clinics: a new role for the pathologist. J. Clin. Pathol. 52 (1999) 723-724
159. Di Paolo M., Luchini D., Bloise R., and Priori S.G. Postmortem molecular analysis in victims of sudden unexplained death. Am. J. Forensic Med. Pathol. 25 (2004) 182-184
160. Sobrino B., Brión M., and Carracedo A. SNPs in forensic genetics: a review on SNP typing methodologies. Forensic Sci. Int. 154 2-3 (2005) 181-194
161. M. Brion, C. Allegue, M. Torres, I. Quintela, L. Concheiro, M.S. Rodríguez-Calvo, A. Carracedo, Finding genetic causes of sudden cardiac death, Forensic Sci. Int.: Genetics, in press.
162. Behr E., Wood D.A., Wright M., Syrris P., Sheppard M.N., Casey A., Davies M.J., McKenna W., and Sudden Arrhythmic Death Syndrome Steering Group. Cardiological assessment of first degree relatives in sudden arrhythmic death syndrome. Lancet 362 (2003) 1457-1459
163. Tan H.L., Hofman N., van Langen I.M., van der Wal A.C., and Wilde A.A. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 112 (2005) 207-213
164. Ackerman M.J., Tester D.J., Porter C.J., and Edwards W.D. Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning. N. Engl. J. Med. 341 (1999) 1121-1125
165. Ackerman M.J., Tester D.J., and Driscoll D.J. Molecular autopsy of sudden unexplained death in the young. Am. J. Forensic Med. Pathol. 22 (2001) 105-111
166. Chugh S.S., Senashova O., Watts A., Tran P.T., Zhou Z., Gong Q., Titus J.L., and Hayflick S.J. Postmortem molecular screening in unexplained sudden death. J. Am. Coll. Cardiol. 43 (2004) 1625-1629
167. Tester D.J., Spoon D.B., Valdivia H.H., Makielski J.C., and Ackerman M.J. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin. Proc. 79 (2004) 1380-1384
168. Priori S.G., Napolitano C., Giordano U., Collisani G., and Memmi M. Brugada syndrome and sudden cardiac death in children. Lancet 355 (2000) 808-809
169. Ackerman M.J., Siu B.L., Sturner W.Q., Tester D.J., Valdivia C.R., Makielski J.C., and Towbin J.A. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. JAMA 286 (2001) 2264-2269
170. Underwood J. Resuscitating the teaching autopsy. BMJ 327 (2003) 803-804